FDA Adverse Event Injury Summary report: N

VITALITY 2

MDR report key: 2040803 · Received April 6, 2011

Report

Report Number
2124215-2011-01440
Event Type
Injury
Date Received
April 6, 2011
Date of Event
January 11, 2011
Report Date
October 12, 2011
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

A DEVICE REPLACEMENT PROCEDURE WILL LIKELY BE PERFORMED IN THE NEAR FUTURE. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. IF ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PATIENT WAS ADMITTED TO THE HOSPITAL DUE TO EXHIBITING END OF LIFE (EOL) BEHAVIOR ALONG WITH DISPLAYING A FAULT CODE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Description of Event or Problem · 1

ADDITIONAL INFORMATION WAS RECEIVED THAT THIS PATIENT WHO'S DEVICE HAD PREVIOUSLY DECLARED EOL, HAD A REMOTE MONITORING REMINDER THAT DEVICE STILL NEEDED TO BE REPLACED AS THE PATIENT IS PACEMAKER DEPENDANT. THE FIELD REPRESENTATIVE NOTED THAT THE PATIENT WAS IN POOR HEALTH, WHICH IS WHY THE DEVICE HAD NOT BEEN REPLACED. BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) WAS CONSULTED ABOUT THE AMOUNT OF PACING REMAINING. TS NOTED THAT POST EOL, PACING IS NOT GUARANTEED AND COULD NOT PREDICT HOW MUCH PACING WAS REMAINING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITALITY 2 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND T165

Patients

Seq Age Sex Outcome Treatment
1 79 YR Hospitalization| R 4087| T165| 0185| 0186